E2F1 and Burkitt lymphoma: Intriguingly, we provide evidence that hsa-miR-9* is able to modulate E2F1 and c-Myc expression, suggesting down-regulation of hsa-miR-9* as a possible mechanism of c-Myc over-expression in BL cases negative for the translocation.